Jefferies Group LLC Mirati Therapeutics, Inc. Put Options Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

Put Options

23 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Sep 21, 2023	SELL	$59.5 - $86.7 $476,000 - $693,600	-8,000 Reduced 17.94%	36,600 $2.56 Million
Q3 2022 Nov 14, 2022	SELL	$59.5 - $86.7 $476,000 - $693,600	-8,000 Reduced 17.94%	36,600 $2.56 Million
Q2 2022 Sep 21, 2023	SELL	$39.16 - $88.71 $3.69 Million - $8.36 Million	-94,200 Reduced 67.87%	44,600 $2.99 Million
Q2 2022 Aug 15, 2022	SELL	$39.16 - $88.71 $3.69 Million - $8.36 Million	-94,200 Reduced 67.87%	44,600 $2.99 Million
Q1 2022 Sep 21, 2023	BUY	$75.82 - $150.97 $8.2 Million - $16.3 Million	108,200 Added 353.59%	138,800 $11.4 Million

Q1 2022 May 16, 2022	BUY	$75.82 - $150.97 $8.2 Million - $16.3 Million	108,200 Added 353.59%	138,800 $11.4 Million
Q3 2021 Sep 21, 2023	SELL	$132.13 - $177.45 $594,585 - $798,525	-4,500 Reduced 12.82%	30,600 $5.41 Million
Q3 2021 Nov 15, 2021	SELL	$132.13 - $177.45 $594,585 - $798,525	-4,500 Reduced 12.82%	30,600 $5.41 Million
Q2 2021 Sep 21, 2023	SELL	$144.0 - $179.73 $460,800 - $575,136	-3,200 Reduced 8.36%	35,100 $5.67 Million
Q2 2021 Aug 20, 2021	SELL	$144.0 - $179.73 $500 Million - $625 Million	-3,474,900 Reduced 99.0%	35,100 $5.67 Million
Q2 2021 Aug 16, 2021	BUY	$144.0 - $179.73 $500 Million - $624 Million	3,471,700 Added 9064.49%	3,510,000 $5.67 Million
Q1 2021 Sep 21, 2023	SELL	$158.92 - $221.61 $24.2 Million - $33.8 Million	-152,500 Reduced 79.93%	38,300 $6.56 Million
Q1 2021 May 14, 2021	SELL	$158.92 - $221.61 $24.2 Million - $33.8 Million	-152,500 Reduced 79.93%	38,300 $6.56 Million
Q4 2020 Sep 21, 2023	BUY	$162.05 - $240.27 $25 Million - $37 Million	154,200 Added 421.31%	190,800 $41.9 Million
Q4 2020 Feb 16, 2021	BUY	$162.05 - $240.27 $2.16 Million - $3.2 Million	13,300 Added 7.49%	190,800 $41.9 Million
Q3 2020 Nov 13, 2020	BUY	$113.26 - $167.27 $4.1 Million - $6.06 Million	36,200 Added 25.62%	177,500 $29.5 Million
Q1 2020 May 15, 2020	SELL	$69.78 - $116.21 $348,900 - $581,050	-5,000 Reduced 3.42%	141,300 $10.9 Million
Q4 2019 Feb 13, 2020	BUY	$70.76 - $128.86 $1.54 Million - $2.81 Million	21,800 Added 17.51%	146,300 $18.9 Million
Q3 2019 Nov 13, 2019	BUY	$77.91 - $109.6 $7.36 Million - $10.4 Million	94,500 Added 315.0%	124,500 $9.7 Million
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $1.65 Million - $2.91 Million	27,800 Added 1263.64%	30,000 $3.09 Million
Q1 2019 May 15, 2019	BUY	$43.65 - $78.95 $96,030 - $173,690	2,200 New	2,200 $161,000
Q4 2018 Feb 14, 2019	SELL	$32.0 - $47.43 $940,800 - $1.39 Million	-29,400 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$47.1 - $62.7 $1.38 Million - $1.84 Million	29,400 New	29,400 $1.39 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account